During the past decade, Kanwal Medical Complex conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kanwal Medical Complex" are "Cytomegalovirus Infection" (1 trials), "Secondary Prevention" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Kanwal Medical Complex" in a lesser frequency.

Most popular intervention types in "Kanwal Medical Complex" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "Placebo" (1 trials), "dabigatran etexilate" (1 trials), "mRNA-1647" (1 trials) and "optional ASA as comedication" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kanwal Medical Complex" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Kanwal Medical Complex". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kanwal Medical Complex, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kanwal Medical Complex, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".